Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-10

Clinical Trial Update: Human Repeated Insult Patch Test [NA]

View source ↗

Summary

Completed human repeated insult patch test study by NeXtGen Biologics for dermatitis/allergy conditions; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NeXtGen Biologics, Inc. | Conditions: Dermatitis, Allergy | NA | Status: COMPLETED | Results posted: 2019-05-10